Q2 2026 Holdings
Filed 2026-08-14 | 156 holdings | $928.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr Series Trust(XBI)Put | ST STR SP BIOT | 78464A870 | $47.5M | 300,000 | 5.1% |
| Abivax SA(ABVX)Call | SPONSORED ADS | 00370M103 | $45.5M | 341,100 | 4.9% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $43.4M | 328,635 | 4.7% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $41.3M | 1,059,730 | 4.4% |
| Abivax SA(ABVX)Put | SPONSORED ADS | 00370M103 | $33.3M | 250,000 | 3.6% |
| Ionis Pharmaceuticals Inc(IONS)Call | COM | 462222100 | $31.7M | 400,000 | 3.4% |
| Moderna Inc(MRNA)Put | COM | 60770K107 | $28.0M | 400,000 | 3.0% |
| Alumis Inc(ALMS) | COM | 022307102 | $24.5M | 870,548 | 2.6% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $24.4M | 72,842 | 2.6% |
| Ionis Pharmaceuticals Inc(IONS)Put | COM | 462222100 | $23.8M | 300,000 | 2.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $22.6M | 388,682 | 2.4% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $22.5M | 272,085 | 2.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $17.8M | 478,500 | 1.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $15.6M | 504,559 | 1.7% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $14.9M | 2,148,359 | 1.6% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $14.5M | 604,215 | 1.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $14.3M | 370,084 | 1.5% |
| Newamsterdam Pharma CompanyPut | PUT | N62509959 | $13.6M | 400,000 | 1.5% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $13.3M | 310,000 | 1.4% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $13.2M | 807,874 | 1.4% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $11.5M | 787,600 | 1.2% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $11.4M | 2,433,000 | 1.2% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $11.3M | 378,999 | 1.2% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $11.1M | 748,181 | 1.2% |
| Connect Biopharma Hldgs LTD(CNTB) | SHS | G23549101 | $10.8M | 4,538,534 | 1.2% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $10.7M | 407,338 | 1.2% |
| Pharvaris N V(PHVS) | COM | N69605108 | $10.7M | 308,856 | 1.2% |
| Alumis Inc(ALMS)Call | COM | 022307102 | $10.0M | 356,300 | 1.1% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $9.5M | 427,349 | 1.0% |
| Damora Therapeutics Inc(GLTO) | COM NEW | 36322Q206 | $8.7M | 335,710 | 0.9% |
| Kodiak Sciences Inc(KOD)Call | COM | 50015M109 | $8.5M | 217,700 | 0.9% |
| Capricor Therapeutics Inc(CAPR)Call | COM NEW | 14070B309 | $8.4M | 350,000 | 0.9% |
| Arrowhead Pharmaceuticals in(ARWR)Put | COM | 04280A100 | $8.2M | 100,000 | 0.9% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $7.8M | 425,000 | 0.8% |
| Pelthos Therapeutics Inc(PTHS) | COM SHS | 171126204 | $7.3M | 256,598 | 0.8% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $7.2M | 1,218,492 | 0.8% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $7.1M | 205,837 | 0.8% |
| Praxis Precision Medicines I(PRAX)Call | COM NEW | 74006W207 | $6.7M | 20,000 | 0.7% |
| Spruce Biosciences Inc(SPRB) | COM NEW | 85209E208 | $6.6M | 121,356 | 0.7% |
| Hims & Hers Health Inc(HIMS) | COM CL A | 433000106 | $6.5M | 188,381 | 0.7% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $6.4M | 126,541 | 0.7% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $6.4M | 3,425,930 | 0.7% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $6.2M | 88,951 | 0.7% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $6.1M | 2,269,704 | 0.7% |
| Ocugen Inc(OCGN) | COM | 67577C105 | $6.1M | 3,962,972 | 0.7% |
| Alpha Cognition Inc(ACOG) | COM NEW | 02074J501 | $6.0M | 836,259 | 0.7% |
| Kymera Therapeutics Inc(KYMR)Put | COM | 501575104 | $5.8M | 50,400 | 0.6% |
| Harrow Inc(HROW) | COM | 415858109 | $5.8M | 135,775 | 0.6% |
| Kazia Therapeutics LTD | SPONSORED ADS | 48669G303 | $5.6M | 396,201 | 0.6% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $5.5M | 165,617 | 0.6% |